Nefiracetam: A Powerful Nootropic for Cognitive Enhancement
Nefiracetam is a potent nootropic compound, known for its cognitive-enhancing effects It belongs to the racetam family of nootropics and is recognized for its ability to improve memory, learning capacity, and concentration.
Supplement Summary
| Name | Nefiracetam |
|---|---|
| Category | Cognitive Function / Nootropics |
| Main Uses |
|
| Effectiveness | Moderate to High, although more extensive human studies are needed for definitive conclusions. |
| Common Dosage | 150-450 mg taken 2-3 times daily |
| Price Range | $20-50 per month |
| Forms Available | Capsules Powder |
Pros
- ✅ Improves learning and memory
- ✅ Enhances concentration
- ✅ Boosts mood
- ✅ Potentially reduces anxiety
- ✅ May delay cognitive decline
Cons / Side Effects
- ❌ Limited human studies
- ❌ Potential for side effects like headaches, nausea, and insomnia
What Is Nefiracetam?
Nefiracetam is a potent nootropic compound, known for its cognitive-enhancing effects. It belongs to the racetam family of nootropics and is recognized for its ability to improve memory, learning capacity, and concentration.
How It Works
Nefiracetam works by modulating neurotransmitters in the brain, notably acetylcholine and glutamate, which are essential for cognitive functions. It also enhances calcium influx into neurons, promoting neuronal plasticity, which is critical for learning and memory.
Who It's Best For
Individuals seeking cognitive enhancement, particularly improved memory and learning capacity. It may also be beneficial for those experiencing mood issues or anxiety.
Who Should Avoid It
People with pre-existing medical conditions, especially liver or kidney diseases, should avoid Nefiracetam. Also, it's not recommended for pregnant or breastfeeding women.
Dosage & Usage Tips
Nefiracetam's typical dosage is 150-450 mg, taken 2-3 times daily. It's recommended to start with a low dose and gradually increase as needed, under the supervision of a healthcare provider.
Buying Advice & Quality Tips
When purchasing Nefiracetam, opt for products from reputable companies. Look for products that are third-party tested for purity and potency.
Price & Value
Given the potential cognitive benefits of Nefiracetam, its cost is reasonable compared to other nootropics. However, the price can vary widely depending on the brand and product quality.
Final Verdict
Nefiracetam is a promising nootropic for cognitive enhancement. However, due to limited human studies and potential side effects, it should be used cautiously and under the supervision of a healthcare provider.
Additional Clinical Research
I have identified three published scientific studies that specifically investigate the effects of nefiracetam. Below is a summary of these studies, categorized by health benefit, along with an assessment of the research quality.
RESEARCH SUMMARY: Nefiracetam
KEY FINDINGS:
Cognitive Function Improvement
- Nefiracetam improved learning and memory deficits in rats with cerebral embolism.
- Study involved male Wistar rats with experimentally induced cerebral embolism; daily oral administration of 30 mg/kg nefiracetam started 9 days post-embolization.
Source: Watabe et al. (1992)
View Research
https://pubmed.ncbi.nlm.nih.gov/1492838/
Poststroke Depression Treatment
- Nefiracetam was not more effective than placebo in treating poststroke depression, except in the most severely depressed patients where 900 mg showed significant improvement.
- Study included 159 patients with major depression post-stroke, randomized to receive 600 mg or 900 mg of nefiracetam or placebo over 12 weeks.
Source: Robinson et al. (2008)
View Research
https://pubmed.ncbi.nlm.nih.gov/18451188/
Poststroke Apathy Treatment
- Nefiracetam did not prove more efficacious than placebo in ameliorating apathy in stroke patients.
- Study was a randomized, placebo-controlled, double-blind trial involving 13 patients with poststroke apathy, receiving 900 mg/day nefiracetam or placebo for 12 weeks.
Source: Starkstein et al. (2016)
View Research
https://pubmed.ncbi.nlm.nih.gov/26915605/
RESEARCH QUALITY ASSESSMENT:
- Studies employed randomized, placebo-controlled, double-blind designs, enhancing reliability.
- Sample sizes were limited, particularly in the study on poststroke apathy, affecting generalizability.
- Animal studies provide preliminary insights but require cautious extrapolation to humans.
- Further large-scale, multicenter trials are necessary to conclusively determine nefiracetam's efficacy in treating cognitive impairments and mood disorders post-stroke.